Method for improving in-vitro maturation and development rate of porcine oocytes by adopting agomelatine
A technology of agomelatine and oocytes, applied in germ cells, animal cells, vertebrate cells, etc., can solve the problems of insufficient antioxidant defense, reduce the in vitro development rate of oocytes and embryos, and improve pig The effect of oocyte quality and in vitro development ability of PA embryos, improvement of blastocyst development ability, and reduction of expression level
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0032] The method for improving the in vitro maturation and development rate of porcine oocytes by using agomelatine comprises the following steps:
[0033] 1) Prepare oocyte maturation medium:
[0034] A culture medium: 80% volume of TCM199, 10% volume of porcine follicular fluid, 10% volume of fetal bovine serum, 0.1g / L cysteine, 0.075g / L penicillin, 0.05g / L streptomycin, 10ng / mL insulin-like growth factor, 50ng / mL epidermal growth factor, 2.2g / L NaHCO 3 , 10IU / mL pregnant horse serum gonadotropin, 10IU / mL human chorionic gonadotropin, 10 - 11 The agomelatine of mol / L concentration;
[0035] B culture fluid: 80% volume of TCM199, 10% volume of porcine follicular fluid, 10% volume of fetal bovine serum, 0.1g / L cysteine, 0.075g / L penicillin, 0.05g / L streptomycin, 10ng / mL insulin-like growth factor, 50ng / mL epidermal growth factor, 2.2g / L NaHCO 3 、10 -11 The agomelatine of mol / L concentration;
[0036] 2) Prepare electroactivation solution: 0.3mmol / L mannitol, 0.1mmol / ...
Embodiment 2
[0042] Adopt agomelatine to improve the method of porcine oocyte maturation and development rate in vitro, compared with embodiment 1, the consumption of agomelatine in step 1) is 1 * 10 -10 mol / L, others are the same as in Example 1.
Embodiment 3
[0044] Adopt agomelatine to improve the method of porcine oocyte maturation and development rate in vitro, compared with embodiment 1, the consumption of agomelatine in step 1) is 1 * 10 -9 mol / L, others are the same as in Example 1.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com